Rat NAD+-dependent 3α-hydroxysteroid dehydrogenase (AKR1C17): A member of the aldo-keto reductase family highly expressed in kidney cytosol

Archives of Biochemistry and Biophysics

Volumn 464, Issue 1, 2007, Pages 122-129

  Sanai, Masaharu ^a   Endo, Satoshi ^a   Matsunaga, Toshiyuki ^a   Ishikura, Shuhei ^a   Tajima, Kazuo ^b   El Kabbani, Ossama ^c   Hara, Akira ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

^c MONASH UNIVERSITY   (Australia)

Author keywords

3 Hydroxysteroid dehydrogenase; AKR1C17; Aldo keto reductase superfamily; Bile acid; Coenzyme specificity; Inhibitor sensitivity; Ketamine; Kidney specific protein; Organic anion; Site directed mutagenesis

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; 8 ANILINO 1 NAPHTHALENESULFONIC ACID; ALDO KETO REDUCTASE; AMARANTH; ANION; BROMSULFOPHTHALEIN; GLYCYRRHETINIC ACID; INDIGO CARMINE; INDOMETACIN; KETAMINE; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; PHENOLSULFONPHTHALEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BILE ACID METABOLISM; CONTROLLED STUDY; CYTOSOL; ENZYME ANALYSIS; ENZYME SPECIFICITY; KIDNEY EPITHELIUM; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATION; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; SENSITIVITY ANALYSIS;

20-HYDROXYSTEROID DEHYDROGENASES; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE (B-SPECIFIC); ANIMALS; CYTOSOL; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROGEN-ION CONCENTRATION; KETONE OXIDOREDUCTASES; KIDNEY; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; RATS; RATS, WISTAR; SUBSTRATE SPECIFICITY;

MAMMALIA; RATTUS;

EID: 34447639776     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2007.04.003     Document Type: Article

References (49)

1. Penning T.M. Endocr. Rev. 18 (1997) 281-305
2. Rupprecht R., and Holsboer F. Trends Neurosci. 22 (1999) 410-416
3. Labrie F., Luu-The V., Lin S.-X., Labrie C., Simard J., Breton R., and Bélanger A. Steroids 62 (1997) 148-158
4. Ishikura S., Usami N., Kitahara K., Isaji T., Oda K., Nakagawa J., and Hara A. Biochemistry 40 (2001) 214-224
5. Biswas M.G., and Russell D.W. J. Biol. Chem. 272 (1997) 15959-15966
6. Chetyrkin S.V., Belyaeva O.V., Gough W.H., and Kedishvili N.Y. J. Biol. Chem. 276 (2001) 22278-22286
7. Chetyrkin S.V., Hu J., Gough W.H., Dumaual N., and Kedishvili N.Y. Arch. Biochem. Biophys. 386 (2001) 1-10
8. Degtigar W.G., and Kushlinsky N.E. Biochemistry (Moscow) 66 (2001) 318-331
9. Higaki Y., Kamiya T., Usami N., Shintani S., Shiraishi H., Ishikura S., Yamamoto I., and Hara A. Drug Metab. Pharmacokin. 17 (2002) 348-356
10. Ishikura S., Nakajima S., Carbone V., El-Kabbani O., and Hara A. In: Weiner H., Plapp B., Lindahl R., and Maser E. (Eds). Enzymology and Molecular Biology of Carbonyl Metabolism 12 (2005), Purdue University Press, West Lafayette 324-332
11. Pawlowski J.E., Huizinga M., and Penning T.M. J. Biol. Chem. 266 (1991) 8820-8825
12. Hyndman D., Bauman D.R., Heredia V.V., and Penning T.M. Chem. Biol. Interact. 143-144 (2003) 499-525
13. Penning T.M., Mukharji I., Barrows S., and Talalay P. Biochem. J. 222 (1984) 601-611
14. Hou Y.-T., Xia W., Pawlowski J.E., and Penning T.M. Cancer Res. 54 (1994) 247-255
15. Matsunaga T., Shintani S., and Hara A. Drug Metab. Pharmacokin. 21 (2006) 1-18
16. Penning T.M., Burczynski M.E., Jez J.M., Hung C.-F., Lin H.-K., Ma H., Moode M., Palackal N., and Patnam K. Biochem. J. 351 (2000) 67-77
17. Luu-The V., Dufort I., Pelletier G., and Labrie F. Mol. Cell. Endocrinol. 171 (2001) 77-81
18. Ishikura S., Usami N., Nakajima S., Kameyama A., Shiraishi H., Carbone V., El-Kabbani O., and Hara A. Biol. Pharm. Bull. 27 (2004) 1939-1945
19. Matsumoto K., Endo S., Ishikura S., Matsunaga T., Tajima K., El-Kabbani O., and Hara A. Biol. Pharm. Bull. 29 (2006) 539-542
20. Mao J., Duan W.R., Albarracin C.T., Parmer T.G., and Gibori G. Biochem. Biophys. Res. Commun. 201 (1994) 1289-1295
21. Ishikura S., Matsumoto K., Sanai M., Horie K., Matsunaga T., Tajima K., El-Kabbani O., and Hara A. J. Biochem. (Tokyo) 139 (2006) 1053-1063
22. Qin K.-N., and Cheng K.-C. Biochemistry 33 (1994) 3223-3228
23. Tajima K., Hashizaki M., Yamamoto K., and Mizutani T. Drug Metab. Dispos. 20 (1992) 816-820
24. Platt K.L., and Oesch F. Synthesis 7 (1977) 449-450
25. Nakanishi M., Deyashiki Y., Ohshima K., and Hara A. Eur. J. Biochem. 228 (1995) 381-387
26. Bradford M.M. Anal. Biochem. 72 (1976) 248-254
27. Cornish-Bowden A. Principles of Enzyme Kinetics (1976), Butter-worths, London 57-60
28. Sakakura H., Suzuki M., Kimura N., Takeda H., Nagata S., and Maeda M. J. Chromatogr. 621 (1993) 123-131
29. Segel I.H. Enzyme Kinetics (1975), John Wiley and Sons, New York 474-656
30. Bennett M.J., Albert R.H., Jez J.M., Ma H., Penning T.M., and Lewis M. Structure 5 (1997) 799-812
31. Jin Y., Stayrook D.E., Albert R.H., Palackal N.T., Penning T.M., and Lewis M. Biochemistry 40 (2001) 10161-10168
32. Couture J.-F., Legrand P., Cantin L., Luu-The V., Labrie F., and Breton R. J. Mol. Biol. 331 (2003) 593-604
33. Ishikura S., Horie K., Sanai M., Matsumoto K., and Hara A. Biol. Pharm. Bull. 28 (2005) 1075-1078
34. Endo S., Matsumoto K., Matsunaga T., Ishikura S., Tajima K., El-Kabbani O., and Hara A. Biol. Pharm. Bull. 29 (2006) 2488-2492
35. Deyashiki Y., Takatsuji T., and Hara A. In: Penning T.M., and Petrash J.M. (Eds). Aldo-keto Reductases and Toxicant Metabolism (2004), American Chemical Society, Washington, DC 101-114
36. Todaka T., Yamano S., and Toki S. Arch. Biochem. Biophys. 374 (2000) 189-197
37. Bellamacina C.R. FASEB J. 10 (1996) 1257-1269
38. Tanaka N., Nonaka T., Tanabe T., Yoshimoto T., Tsuru D., and Mitsui Y. Biochemistry 35 (1996) 7715-7730
39. Perozich J., Kuo I., Wang B.C., Boesch J.S., Lindahl R., and Hempel J. Eur. J. Biochem. 267 (2000) 6197-6203
40. Krasowski D., Yasuda K., Hagey L.R., and Schuetz E.G. Mol. Endocrinol. 19 (2005) 1720-1739
41. Makishima M., Okamoto A.Y., Repa J.J., Tu H., Learned R.M., Luk A., Hull M.V., Lustig K.D., Mangelsdorf D.J., and Shan B. Science 284 (1999) 1362-1365
42. Souidi M., Gueguen Y., Linard C., Dudoignon N., Grison S., Baudelin C., Marquette C., Gourmelon P., Aigueperse J., and Dublineau I. Toxicology 214 (2005) 113-122
43. Ackermann D., Vogt B., Escher G., Dicj B., Reichen J., Frey B.M., and Frey F.J. Hepatology 30 (1999) 623-629
44. Wilson F.A., Burckhardt G., Murer H., Rumrich G., and Ullrich K.J. J. Clin. Invest. 67 (1981) 1141-1150
45. Christie D.M., Dawson P.A., Thevananther S., and Shneider B.L. Am. J. Physiol. 271 (1996) G377-G385
46. Schlattjan J.H., Winter C., and Greven J. Nephron Physiol. 95 (2003) 49-56
47. Stolz A., Takikawa H., Sugiyama Y., Kuhlenkamp J., and Kaplowitz N. J. Clin. Invest. 79 (1987) 427-434
48. Sugiyama Y., Yamada T., and Kaplowitz N. J. Biol. Chem. 258 (1983) 3602-3607
49. Takikawa H., Sugiyama Y., Stolz A., Sugimoto A., and Kaplowitz N. Biochem. Pharmacol. 35 (1986) 354-356